Show simple item record

dc.contributor.authorJohnston, Amyen_US
dc.contributor.authorBurne, Thomasen_US
dc.contributor.authorSilburn, P.en_US
dc.contributor.authorMackay-Sim, Alanen_US
dc.date.accessioned2017-04-24T11:45:08Z
dc.date.available2017-04-24T11:45:08Z
dc.date.issued2007en_US
dc.date.modified2009-10-01T05:55:11Z
dc.identifier.urihttp://hdl.handle.net/10072/18080
dc.description.abstractOlfactory function is impaired in the majority of persons with Parkinson's disease (PD). Olfactory dysfunction occurs early in the disease and is a proposed means of premorbid disease detection. However, the level of olfactory impairment is not universal in PD patients. This variability may be attributed to differences in the Parkinson's disease process or other idiopathic variability resulting from unidentified age-associated health and medication effects, as seen in normative populations. We assessed olfactory function from patients with PD using the 'Sniffin' sticks' tests and compared these data to results collected from the healthy Australian population. We found little evidence of presbyosmia (age-associated idiopathic loss of smell) in the general population, when controlling for other factors such as history of medication and upper respiratory disease, and showed that many people with clinically diagnosed PD retain significant olfactory function, even compared with healthy age and sex-matched controls. We also found relatively little change in longitudinal olfactory function in PD patients, across an 18 month period, irrespective of the prior disease duration. Curiously, patients receiving different medications performed significantly differently, suggesting that medication status may exacerbate olfactory dysfunction in this patient group. This is particularly significant given the high rate of prescription of these drugs; more than 300,000 scripts (>$23 million) were issued in 2003 in Australia alone (PBS, Australia). These findings will be discussed in the context of non-neurological factors impacting on smell in an aging population.en_US
dc.description.publicationstatusYesen_AU
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherNo data provideden_US
dc.publisher.urihttp://www.ibro.org/Pub/Pub_Front.asp?en_AU
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofconferencenameInternational brain research organizationen_US
dc.relation.ispartofconferencetitlePresbyosmia, Parkinson’s and Pharmaceutically-induced loss of olfactory functionen_US
dc.relation.ispartofdatefrom2007-07-12en_US
dc.relation.ispartofdateto2007-07-17en_US
dc.relation.ispartoflocationMelbourneen_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchcode270502en_US
dc.subject.fieldofresearchcode320705en_US
dc.titlePresbyosmia, Parkinson’s and Pharmaceutically-induced loss of olfactory functionen_US
dc.typeConference outputen_US
dc.type.descriptionE3 - Conference Publications (Extract Paper)en_US
dc.type.codeE - Conference Publicationsen_US
gro.facultyGriffith Health, School of Nursing and Midwiferyen_US
gro.date.issued2007
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record